161 related articles for article (PubMed ID: 33095437)
1. The Chronic Treatment With 5-HT
Tsybko AS; Ilchibaeva TV; Filimonova EA; Eremin DV; Popova NK; Naumenko VS
Neurochem Res; 2020 Dec; 45(12):3059-3075. PubMed ID: 33095437
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
3. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
[TBL] [Abstract][Full Text] [Related]
4. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
[TBL] [Abstract][Full Text] [Related]
5. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
6. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor β deficiency impairs BDNF-5-HT
Chhibber A; Woody SK; Karim Rumi MA; Soares MJ; Zhao L
Psychoneuroendocrinology; 2017 Aug; 82():107-116. PubMed ID: 28544903
[TBL] [Abstract][Full Text] [Related]
8. A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.
Hagsäter SM; Pettersson R; Pettersson C; Atanasovski D; Näslund J; Eriksson E
Int J Neuropsychopharmacol; 2021 Sep; 24(9):749-757. PubMed ID: 34228806
[TBL] [Abstract][Full Text] [Related]
9. Effect of a hallucinogenic serotonin 5-HT
Zhang G; Cinalli D; Stackman RW
Hippocampus; 2017 May; 27(5):558-569. PubMed ID: 28176400
[TBL] [Abstract][Full Text] [Related]
10. Genetically defined fear-induced aggression: Focus on BDNF and its receptors.
Ilchibaeva TV; Tsybko AS; Kozhemyakina RV; Kondaurova EM; Popova NK; Naumenko VS
Behav Brain Res; 2018 May; 343():102-110. PubMed ID: 29425916
[TBL] [Abstract][Full Text] [Related]
11. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.
Märcher Rørsted E; Jensen AA; Kristensen JL
ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515
[TBL] [Abstract][Full Text] [Related]
12. 5-HT
Gao J; Chen L; Li M
Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.
Odland AU; Kristensen JL; Andreasen JT
Behav Pharmacol; 2021 Aug; 32(5):448-452. PubMed ID: 33595957
[TBL] [Abstract][Full Text] [Related]
14. The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.
Odland AU; Jessen L; Kristensen JL; Fitzpatrick CM; Andreasen JT
Neuropharmacology; 2021 Feb; 183():107838. PubMed ID: 31693871
[TBL] [Abstract][Full Text] [Related]
15. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain.
Breusova K; Ernstsen KG; Palner M; Linnet K; Kristensen JL; Kretschmann AC
J Pharm Biomed Anal; 2021 May; 199():114016. PubMed ID: 33784574
[TBL] [Abstract][Full Text] [Related]
16. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
17. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
[TBL] [Abstract][Full Text] [Related]
18. BDNF-TrkB/proBDNF-p75
Jia D; Wang F; Bai Z; Chen X
Sci Rep; 2023 Oct; 13(1):18364. PubMed ID: 37884604
[TBL] [Abstract][Full Text] [Related]
19. Early Downregulation of p75
Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
[TBL] [Abstract][Full Text] [Related]
20. TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT
Di Giovanni G; De Deurwaerdère P
Neuropharmacology; 2018 Nov; 142():20-29. PubMed ID: 28987938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
